Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic. / Lauridsen, M. D.; Butt, J. H.; Østergaard, L.; Møller, J. E.; Hassager, C.; Gerds, T.; Kragholm, K.; Phelps, M.; Schou, M.; Torp-Pedersen, C.; Gislason, G.; Køber, L.; Fosbøl, E. L.

In: IJC Heart and Vasculature, Vol. 31, 100659, 2020.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lauridsen, MD, Butt, JH, Østergaard, L, Møller, JE, Hassager, C, Gerds, T, Kragholm, K, Phelps, M, Schou, M, Torp-Pedersen, C, Gislason, G, Køber, L & Fosbøl, EL 2020, 'Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic', IJC Heart and Vasculature, vol. 31, 100659. https://doi.org/10.1016/j.ijcha.2020.100659

APA

Lauridsen, M. D., Butt, J. H., Østergaard, L., Møller, J. E., Hassager, C., Gerds, T., Kragholm, K., Phelps, M., Schou, M., Torp-Pedersen, C., Gislason, G., Køber, L., & Fosbøl, E. L. (2020). Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic. IJC Heart and Vasculature, 31, [100659]. https://doi.org/10.1016/j.ijcha.2020.100659

Vancouver

Lauridsen MD, Butt JH, Østergaard L, Møller JE, Hassager C, Gerds T et al. Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic. IJC Heart and Vasculature. 2020;31. 100659. https://doi.org/10.1016/j.ijcha.2020.100659

Author

Lauridsen, M. D. ; Butt, J. H. ; Østergaard, L. ; Møller, J. E. ; Hassager, C. ; Gerds, T. ; Kragholm, K. ; Phelps, M. ; Schou, M. ; Torp-Pedersen, C. ; Gislason, G. ; Køber, L. ; Fosbøl, E. L. / Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic. In: IJC Heart and Vasculature. 2020 ; Vol. 31.

Bibtex

@article{6400cf9cb5184dd28b0955eb035270c5,
title = "Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic",
abstract = "Aims: The hospitalization of patients with MI has decreased during global lockdown due to the COVID-19 pandemic. Whether this decrease is associated with more severe MI, e.g. MI-CS, is unknown. We aimed to examine the association of Corona virus disease (COVID-19) pandemic and incidence of acute myocardial infarction with cardiogenic shock (MI-CS). Methods: On March 11, 2020, the Danish government announced national lock-down. Using Danish nationwide registries, we identified patients hospitalized with MI-CS. Incidence rates (IR) and incidence rate ratios (IRR) were used to compare MI-CS before and after March 11 in 2015–2019 and in 2020. Results: We identified 11,769 patients with MI of whom 696 (5.9%) had cardiogenic shock in 2015–2019. In 2020, 2132 MI patients were identified of whom 119 had cardiogenic shock (5.6%). The IR per 100,000 person years before March 11 in 2015–2019 was 9.2 (95% CI: 8.3–10.2) and after 8.9 (95% CI: 8.0–9.9). In 2020, the IR was 7.5 (95% CI: 5.8–9.7) before March 11 and 7.7 (95% CI: 6.0–9.9) after. The IRRs comparing the 2020-period with the 2015–2019 period before and after March 11 (lockdown) were 0.81 (95% CI: 0.59–1.12) and 0.87 (95% CI: 0.57–1.32), respectively. The IRR comparing the 2020-period during and before lockdown was 1.02 (95% CI: 0.74–1.41). No difference in 7-day mortality or in-hospital management was observed between study periods. Conclusion: We could not identify a significant association of the national lockdown on the incidence of MI-CS, along with similar in-hospital management and mortality in patients with MI-CS.",
keywords = "Cardiogenic shock, Corona virus, COVID-19, Incidence, Myocardial infarction",
author = "Lauridsen, {M. D.} and Butt, {J. H.} and L. {\O}stergaard and M{\o}ller, {J. E.} and C. Hassager and T. Gerds and K. Kragholm and M. Phelps and M. Schou and C. Torp-Pedersen and G. Gislason and L. K{\o}ber and Fosb{\o}l, {E. L.}",
year = "2020",
doi = "10.1016/j.ijcha.2020.100659",
language = "English",
volume = "31",
journal = "IJC Heart and Vasculature",
issn = "2352-9067",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic

AU - Lauridsen, M. D.

AU - Butt, J. H.

AU - Østergaard, L.

AU - Møller, J. E.

AU - Hassager, C.

AU - Gerds, T.

AU - Kragholm, K.

AU - Phelps, M.

AU - Schou, M.

AU - Torp-Pedersen, C.

AU - Gislason, G.

AU - Køber, L.

AU - Fosbøl, E. L.

PY - 2020

Y1 - 2020

N2 - Aims: The hospitalization of patients with MI has decreased during global lockdown due to the COVID-19 pandemic. Whether this decrease is associated with more severe MI, e.g. MI-CS, is unknown. We aimed to examine the association of Corona virus disease (COVID-19) pandemic and incidence of acute myocardial infarction with cardiogenic shock (MI-CS). Methods: On March 11, 2020, the Danish government announced national lock-down. Using Danish nationwide registries, we identified patients hospitalized with MI-CS. Incidence rates (IR) and incidence rate ratios (IRR) were used to compare MI-CS before and after March 11 in 2015–2019 and in 2020. Results: We identified 11,769 patients with MI of whom 696 (5.9%) had cardiogenic shock in 2015–2019. In 2020, 2132 MI patients were identified of whom 119 had cardiogenic shock (5.6%). The IR per 100,000 person years before March 11 in 2015–2019 was 9.2 (95% CI: 8.3–10.2) and after 8.9 (95% CI: 8.0–9.9). In 2020, the IR was 7.5 (95% CI: 5.8–9.7) before March 11 and 7.7 (95% CI: 6.0–9.9) after. The IRRs comparing the 2020-period with the 2015–2019 period before and after March 11 (lockdown) were 0.81 (95% CI: 0.59–1.12) and 0.87 (95% CI: 0.57–1.32), respectively. The IRR comparing the 2020-period during and before lockdown was 1.02 (95% CI: 0.74–1.41). No difference in 7-day mortality or in-hospital management was observed between study periods. Conclusion: We could not identify a significant association of the national lockdown on the incidence of MI-CS, along with similar in-hospital management and mortality in patients with MI-CS.

AB - Aims: The hospitalization of patients with MI has decreased during global lockdown due to the COVID-19 pandemic. Whether this decrease is associated with more severe MI, e.g. MI-CS, is unknown. We aimed to examine the association of Corona virus disease (COVID-19) pandemic and incidence of acute myocardial infarction with cardiogenic shock (MI-CS). Methods: On March 11, 2020, the Danish government announced national lock-down. Using Danish nationwide registries, we identified patients hospitalized with MI-CS. Incidence rates (IR) and incidence rate ratios (IRR) were used to compare MI-CS before and after March 11 in 2015–2019 and in 2020. Results: We identified 11,769 patients with MI of whom 696 (5.9%) had cardiogenic shock in 2015–2019. In 2020, 2132 MI patients were identified of whom 119 had cardiogenic shock (5.6%). The IR per 100,000 person years before March 11 in 2015–2019 was 9.2 (95% CI: 8.3–10.2) and after 8.9 (95% CI: 8.0–9.9). In 2020, the IR was 7.5 (95% CI: 5.8–9.7) before March 11 and 7.7 (95% CI: 6.0–9.9) after. The IRRs comparing the 2020-period with the 2015–2019 period before and after March 11 (lockdown) were 0.81 (95% CI: 0.59–1.12) and 0.87 (95% CI: 0.57–1.32), respectively. The IRR comparing the 2020-period during and before lockdown was 1.02 (95% CI: 0.74–1.41). No difference in 7-day mortality or in-hospital management was observed between study periods. Conclusion: We could not identify a significant association of the national lockdown on the incidence of MI-CS, along with similar in-hospital management and mortality in patients with MI-CS.

KW - Cardiogenic shock

KW - Corona virus

KW - COVID-19

KW - Incidence

KW - Myocardial infarction

U2 - 10.1016/j.ijcha.2020.100659

DO - 10.1016/j.ijcha.2020.100659

M3 - Journal article

C2 - 33072848

AN - SCOPUS:85092907065

VL - 31

JO - IJC Heart and Vasculature

JF - IJC Heart and Vasculature

SN - 2352-9067

M1 - 100659

ER -

ID: 250386362